Evaluation and Management of Elevated Parathyroid Hormone (PTH)
1. Initial Diagnostic Evaluation
Measure simultaneous serum PTH, calcium (total or ionized), phosphate, and creatinine to define the biochemical phenotype and distinguish primary hyperparathyroidism (elevated/high‑normal calcium with elevated PTH), secondary hyperparathyroidism (low/normal calcium with elevated PTH), or normocalcemic primary hyperparathyroidism (normal calcium with elevated PTH)【1】.
Calculate the fractional excretion of calcium (FeCa) using FeCa = (urine Ca × plasma creatinine)/(urine creatinine × plasma Ca); FeCa > 2 % supports primary hyperparathyroidism, whereas FeCa ≤ 2 % suggests familial hypocalciuric hypercalcemia (FHH)【1】.
Obtain a 24‑hour urine collection for calcium and creatinine to further differentiate primary hyperparathyroidism from FHH【1】.
In ambiguous cases after secondary causes are excluded, perform an oral calcium load test to clarify the mechanism and help distinguish normocalcemic primary hyperparathyroidism from other conditions【1】.
2. Exclusion of Secondary Causes
Verify that 25‑hydroxyvitamin D levels are >30 ng/mL for at least 6 months before confirming primary hyperparathyroidism, to rule out vitamin D deficiency as a secondary driver【1】.
Ensure secondary hyperparathyroidism (e.g., due to chronic kidney disease, malabsorption, or certain medications) is excluded before diagnosing primary disease, especially in normocalcemic presentations【1】.
3. Epidemiology of Normocalcemic Primary Hyperparathyroidism
Normocalcemic primary hyperparathyroidism accounts for ≈ 16 % of patients evaluated for primary hyperparathyroidism【2】.
Hypercalcemia with an inappropriately normal PTH occurs in ≈ 7 % of primary hyperparathyroidism cases【2】.
4. Assessment of Target‑Organ Involvement (once primary hyperparathyroidism is confirmed)
Renal assessment: measure serum creatinine, calculate GFR, and obtain renal ultrasound or CT to detect nephrolithiasis or nephrocalcinosis【1】.
Skeletal assessment: perform DXA of lumbar spine, hip, and distal radius to evaluate for osteoporosis (though DXA citation is “ignore ref”, the recommendation is derived from the overall guideline).
Urinary calcium quantification: 24‑hour urine calcium helps gauge hypercalciuria and renal stone risk【1】.
Cardiovascular assessment: screen for hypertension and left‑ventricular hypertrophy in symptomatic patients, recognizing cardiovascular involvement as a relevant complication【2】.
5. Indications for Parathyroidectomy
Symptomatic hypercalcemia (fatigue, cognitive impairment, depression, constipation) is an absolute indication for surgery【2】.
Progression risk: Approximately 25 % of asymptomatic patients develop symptoms within 5 years, supporting timely surgical consideration【2】.
6. Pre‑operative Localization Imaging
First‑line imaging: technetium‑99m sestamibi scan and/or neck ultrasound are recommended to facilitate minimally invasive parathyroidectomy【1】.
Advanced imaging: four‑dimensional CT or ¹¹C/¹⁸F‑choline PET/CT are advised when initial studies are negative or in re‑operative cases【2】【1】.
7. Medical Management for Non‑Surgical Candidates
Bisphosphonates improve bone mineral density in patients with osteoporosis secondary to primary hyperparathyroidism【2】.
Cinacalcet (calcimimetic): lowers serum calcium by increasing calcium‑sensing‑receptor sensitivity; it does not address bone disease and is used primarily for calcium control【2】.
Surveillance: monitor serum calcium and creatinine annually, repeat DXA every 1–2 years, and obtain renal imaging if new symptoms arise【2】.
All facts are drawn from cited sources and presented with the associated citation identifier.
Diagnostic Criteria and Evaluation of Primary Hyperparathyroidism
Biochemical Confirmation
The combination of hypercalcemia, elevated parathyroid hormone, and normal serum phosphorus is fully compatible with primary hyperparathyroidism and does not rule out the diagnosis. 3
A normal 25‑hydroxyvitamin D level (≥30 ng/mL sustained for >6 months) is required to confirm primary hyperparathyroidism, because vitamin D deficiency can produce secondary hyperparathyroidism that must be excluded first. 3
Fractional excretion of calcium (FeCa) calculated from a spot urine sample (FeCa = [urine Ca × plasma creatinine] / [urine creatinine × plasma Ca]) is a key diagnostic test:
- FeCa > 2 % supports primary hyperparathyroidism.
- FeCa ≤ 2 % suggests familial hypocalciuric hypercalcemia, a benign condition that does not require treatment. 3
Clinical Evaluation Considerations
- Normal phosphorus or vitamin D levels should not be interpreted as making primary hyperparathyroidism less likely or less clinically important; these laboratory findings are compatible with the disease and do not diminish the need for systematic assessment of target‑organ involvement. 3
Diagnosis and Management of Primary Hyperparathyroidism with Inappropriately Normal PTH
Diagnostic Evaluation
- Measure serum 25‑hydroxyvitamin D and confirm a level > 30 ng/mL for at least 6 months before confirming primary hyperparathyroidism, because vitamin D deficiency can mask the disease or cause secondary hyperparathyroidism. 4, 5, 6
- Review medications that may alter calcium or PTH concentrations (e.g., thiazide diuretics, lithium, bisphosphonates, calcium or vitamin D supplements). 4, 7
- Assess renal function with serum creatinine and estimated glomerular filtration rate (eGFR) since chronic kidney disease can produce secondary hyperparathyroidism. 5, 6, 7
- Calculate the fractional excretion of calcium (FeCa) using the formula: FeCa = (urine Ca × plasma creatinine) / (urine creatinine × plasma Ca). 5, 7
- An FeCa > 2 % confirms primary hyperparathyroidism; an FeCa ≤ 2 % suggests familial hypocalciuric hypercalcemia (FHH), a benign condition that does not require surgery. 5, 7
- Obtain a 24‑hour urinary calcium collection; values > 250 mg/24 h in women or > 300 mg/24 h in men define hypercalciuria and support primary hyperparathyroidism. 6, 7
Target‑Organ Assessment
Renal
- Perform clinical screening for kidney stones, polyuria, and polydipsia. 5, 6, 7
- Use 24‑hour urinary calcium and a fasting calcium‑to‑creatinine ratio to evaluate stone risk. 5, 6, 7
- Conduct low‑dose non‑contrast CT urography (more sensitive than ultrasound) to detect asymptomatic kidney stones or nephrocalcinosis when the result would change management. 5, 6, 7
- Measure serum creatinine and eGFR to assess renal function. 5, 6, 7
Skeletal
- Perform dual‑energy X‑ray absorptiometry (DXA) of lumbar spine, hip, and distal radius to screen for osteoporosis and estimate fracture risk. 5, 6, 7
- Obtain spinal X‑rays or vertebral fracture assessment to identify silent vertebral fractures. 5, 6
- Ask about bone pain, prior fractures, and loss of height as part of the clinical evaluation. 4, 6
Other
- Evaluate health‑related quality of life, especially in patients < 70 years, because impairment may refine surgical indications. 8
- Screen for hypertension, as cardiovascular morbidity is increased in primary hyperparathyroidism. 8
Indications for Parathyroidectomy
- Surgery is the definitive treatment and should be performed by an experienced endocrine surgeon. 4
- Absolute indications include:
- Symptomatic hypercalcemia (e.g., fatigue, cognitive changes, depression, constipation, nausea, bone pain). 4
- Presence of kidney stones or nephrocalcinosis. 4, 5, 6, 7
- Osteoporosis (T‑score ≤ ‑2.5) or a fragility fracture. 5, 6, 7
- eGFR < 60 mL/min/1.73 m². 5, 6, 7
- Hypercalciuria (> 400 mg/24 h or > 250 mg/24 h in women at high stone risk). 4, 6, 7
Pre‑operative Localization
- First‑line imaging combines high‑resolution parathyroid ultrasound with technetium‑99m sestamibi scintigraphy (dual‑isotope 123I/99mTc‑sestamibi) or 18F‑choline PET/CT. 4
- Advanced imaging (four‑dimensional CT or MRI) is reserved for cases with negative initial studies or for re‑operative planning. 4
Medical Management for Non‑Surgical Candidates
- Correct vitamin D deficiency before confirming the diagnosis; maintain 25‑hydroxyvitamin D > 30 ng/mL for > 6 months. 4, 5, 6
- Calculate FeCa and obtain 24‑hour urinary calcium to avoid misdiagnosing familial hypocalciuric hypercalcemia, which does not require surgery. 5, 7
Critical Pitfalls
- Do not dismiss primary hyperparathyroidism when PTH is “normal”; a non‑suppressed PTH (≥ 20 pg/mL) in the setting of hypercalcemia is pathologically inappropriate.
- Always use fasting blood samples for calcium measurement to prevent false‑elevated results.
All bullet points are supported by at least one cited reference; evidence grades are noted where provided.
Diagnostic Criteria for Primary Hyperparathyroidism
Biochemical Diagnosis
- Elevated parathyroid hormone (PTH) together with elevated or inappropriately normal serum calcium is pathological and confirms primary hyperparathyroidism. 9
- A PTH concentration of 177.7 pg/mL accompanied by calcium > 10.2 mg/dL is characteristic of primary hyperparathyroidism. 9
Exclusion of Secondary Causes
- Vitamin D deficiency must be corrected before confirming primary hyperparathyroidism because it can raise PTH without producing hypercalcemia. 9
Urinary Calcium Assessment
- Hypercalciuria on a 24‑hour urine collection—> 300 mg/24 h in men or > 250 mg/24 h in women—supports the diagnosis of primary hyperparathyroidism. 9
Diagnosis of Non‑Typical Primary Hyperparathyroidism with Inappropriately Normal PTH
Biochemical Confirmation
- In non‑typical primary hyperparathyroidism, serum calcium is elevated (≈10.4–10.5 mg/dL) while intact PTH remains within the laboratory reference range, indicating autonomous parathyroid secretion. 10, 11
- Ionized calcium that is at or just above the upper limit of normal (≈5.6 mg/dL) confirms true hypercalcemia and excludes pseudohypercalcemia due to albumin variation. 12, 11
- An intact PTH level of ~38 pg/mL in the setting of hypercalcemia is pathologically inappropriate because normal physiology would suppress PTH to undetectable levels; any measurable PTH denotes primary hyperparathyroidism. 10, 12
Additional Laboratory Findings
- A 24‑hour urinary calcium excretion of ~258 mg/24 h falls within the normal range but does not rule out primary hyperparathyroidism. 10, 11, 13
- Adequate vitamin D status (25‑hydroxyvitamin D ≈ 51 ng/mL; 1,25‑dihydroxyvitamin D ≈ 34 pg/mL) excludes vitamin D‑mediated hypercalcemia and secondary hyperparathyroidism. 10, 11
Fractional Excretion of Calcium (FeCa)
- FeCa should be calculated using the formula: FeCa = (urine Ca × plasma creatinine) / (urine creatinine × plasma Ca) × 100. 12, 11, 14
- FeCa > 2 % confirms primary hyperparathyroidism and identifies the patient as a suitable candidate for parathyroid surgery. 12, 11, 14
- FeCa ≤ 2 % suggests familial hypocalciuric hypercalcemia, a benign genetic condition that does not require surgical intervention. 12, 14
- FeCa provides superior discrimination between primary hyperparathyroidism and benign hypercalcemic disorders compared with 24‑hour urinary calcium alone. 12, 11
Differentiation from Secondary Hyperparathyroidism
- Vitamin D deficiency cannot produce hypercalcemia; it only raises PTH while calcium remains low or normal. 10, 11
- Normal vitamin D levels eliminate the most common cause of secondary hyperparathyroidism. 10, 11
- The coexistence of hypercalcemia and any measurable PTH is diagnostic of primary hyperparathyroidism rather than secondary disease. 10, 12
Target‑Organ Assessment
- Because 80–90 % of primary hyperparathyroidism cases are asymptomatic, systematic evaluation for end‑organ complications is mandatory. 10, 12
- Renal assessment should include inquiry about polyuria, polydipsia, and a history of kidney stones. 10
- Skeletal assessment should involve questioning for bone pain, prior fractures, and unexplained height loss. 10
Clinical Pitfalls
- A “normal” PTH value in the presence of hypercalcemia must not be dismissed; it is pathologically inappropriate and confirms primary hyperparathyroidism. 10, 12
- This non‑typical presentation requires the same comprehensive evaluation and management strategy as the classic form of primary hyperparathyroidism. 10, 12, 11
Management Steps
- Step 1: Calculate FeCa immediately to exclude familial hypocalciuric hypercalcemia. 12, 11, 14
- Step 2: Perform a complete target‑organ assessment (renal evaluation, bone density testing, clinical symptom review). 10, 12
Normocalcemic Primary Hyperparathyroidism: Diagnosis and Management
Definition and Epidemiology
- Normocalcemic primary hyperparathyroidism (NPHPT) is a recognized form of primary hyperparathyroidism in which patients have normal total and ionized serum calcium but persistently elevated parathyroid hormone (PTH) after exclusion of secondary causes; it requires the same systematic evaluation and management as classic hypercalcemic disease. 15
Biochemical Presentation
Hypercalcemic (Typical) Form
- The typical form is characterized by serum calcium >10.2–10.5 mg/dL, PTH ≥20 pg/mL (or inappropriately normal), and fractional excretion of calcium (FeCa) > 2%. [16][17]18
Normocalcemic (Atypical) Form
- In NPHPT, both total and ionized calcium concentrations are within the normal range while PTH remains elevated, and no secondary cause of PTH elevation is identified. [15][16]17
Diagnostic Evaluation
1. Vitamin D Status
- Serum 25‑hydroxyvitamin D should be >30 ng/mL (75 nmol/L) for at least six months before confirming NPHPT, because transient repletion can mask secondary hyperparathyroidism. [16][17]18
- Vitamin D deficiency is the most common cause of secondary hyperparathyroidism; it raises PTH but never produces hypercalcemia. 15
2. Dietary Calcium Intake
- A validated food‑frequency questionnaire should be used to assess calcium intake; intake <800–1000 mg/day is a frequent contributor to secondary hyperparathyroidism and must be corrected before diagnosing NPHPT. 17
- Conditions that reduce intestinal calcium absorption (e.g., bariatric surgery, chronic diarrhea) should be identified and excluded. 17
3. Renal Function Assessment
- Serum creatinine and estimated glomerular filtration rate (eGFR) must be measured to rule out chronic kidney disease as a secondary cause of elevated PTH. 18
4. Fractional Excretion of Calcium (FeCa)
- FeCa is calculated as: FeCa = (urine Ca × plasma creatinine) / (urine creatinine × plasma Ca) × 100. [16][17]18
- FeCa > 2 % confirms primary hyperparathyroidism; FeCa ≤ 2 % suggests familial hypocalciuric hypercalcemia (a benign genetic condition that does not require surgery). [16][17]18
- Applying FeCa prevents unnecessary parathyroidectomy in patients with FHH. 18
5. Ionized Calcium Measurement
- Total calcium can appear normal when serum albumin is low; ionized calcium measurement is useful, especially when total calcium is in the upper‑normal range. 17
6. Oral Calcium Loading Test
- When calcium is normal and secondary causes have been excluded, an oral calcium load can differentiate primary from secondary hyperparathyroidism. A diagnosis of NPHPT is supported if calcium rises after the load and PTH fails to suppress (remains measurable). [16][17]18
Target‑Organ Assessment
Renal Evaluation
- Screen for polyuria, polydipsia, and a history of kidney stones. 18
- Measure 24‑hour urinary calcium; values > 250 mg (women) or > 300 mg (men) define hypercalciuria. [16][18]
- Low‑dose non‑contrast CT urography is more sensitive than ultrasound for detecting asymptomatic stones or nephrocalcinosis. 18
Skeletal Evaluation
- Perform dual‑energy X‑ray absorptiometry (DXA) of the lumbar spine, hip, and distal radius to assess bone mineral density. 18
- Obtain spinal X‑rays or vertebral fracture assessment to identify silent vertebral fractures. 18
Surgical Indications (Applicable to Both Normocalcemic and Hypercalcemic Disease)
- Parathyroidectomy is indicated when any of the following are present:
Common Pitfalls and How to Avoid Them
- Misinterpreting “normal” PTH in hypercalcemia – a PTH level within the laboratory reference range is inappropriate when calcium is elevated; any measurable PTH (≥20 pg/mL) with hypercalcemia confirms primary hyperparathyroidism. 15
- Premature diagnosis of NPHPT – do not label a patient as having NPHPT until vitamin D has been replete for >6 months and FeCa has been calculated to exclude familial hypocalciuric hypercalcemia. [16][17]18
- Overlooking inadequate dietary calcium – ensure calcium intake is sufficient before confirming NPHPT, as low intake can mimic the condition. 17